Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS …
LV Boersma, M El-Chami, C Steinwender… - Europace, 2022 - academic.oup.com
Background Leadless cardiac pacemakers (LCPMs) are an emerging alternative to TV-PM 1–
3 to reduce the complications related to TV leads and subcutaneous generator pockets. 4–6 …
3 to reduce the complications related to TV leads and subcutaneous generator pockets. 4–6 …
[HTML][HTML] Efficacy and safety of an extravascular implantable cardioverter–defibrillator
P Friedman, F Murgatroyd, LVA Boersma… - … England Journal of …, 2022 - Mass Medical Soc
Background The extravascular implantable cardioverter–defibrillator (ICD) has a single lead
implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and …
implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and …
Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options
JB Tonko, CA Rinaldi - EP Europace, 2022 - academic.oup.com
Implantable cardioverter-defibrillators (ICDs) have revolutionized the treatment of acquired
or inherited cardiac diseases associated with a high risk of sudden cardiac death due to …
or inherited cardiac diseases associated with a high risk of sudden cardiac death due to …
The extravascular implantable cardioverter‐defibrillator: The pivotal study plan
Background Transvenous implantable cardioverter defibrillators (TV ICD) provide life‐saving
therapy for millions of patients worldwide. However, they are susceptible to several potential …
therapy for millions of patients worldwide. However, they are susceptible to several potential …
Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies
V Sagi, F Murgatroyd, LVA Boersma, J Manlucu… - Europace, 2024 - academic.oup.com
Aims The extravascular implantable cardioverter-defibrillator (EV ICD) has been shown to
be safe and effective for patients at risk of sudden cardiac death, but little is known about EV …
be safe and effective for patients at risk of sudden cardiac death, but little is known about EV …
The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest
AE Thompson, B Atwater, L Boersma… - Journal of …, 2022 - Wiley Online Library
Introduction The extravascular implantable cardioverter‐defibrillator (EV ICD) system with
substernal lead placement is a novel nontransvenous alternative to current commercially …
substernal lead placement is a novel nontransvenous alternative to current commercially …
[HTML][HTML] The subcutaneous ICD: a review of the UNTOUCHED and PRAETORIAN trials
A Karimianpour, L John, MR Gold - Arrhythmia & Electrophysiology …, 2021 - ncbi.nlm.nih.gov
The ICD is an important part of the treatment and prevention of sudden cardiac death in
many high-risk populations. Traditional transvenous ICDs (TV-ICDs) are associated with …
many high-risk populations. Traditional transvenous ICDs (TV-ICDs) are associated with …
Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study
P Friedman, F Murgatroyd, LVA Boersma, J Manlucu… - Circulation, 2024 - ahajournals.org
Background: Substernal lead placement of the extravascular implantable cardioverter-
defibrillator (EV ICD) permits both defibrillation at thresholds similar to those seen with …
defibrillator (EV ICD) permits both defibrillation at thresholds similar to those seen with …
Design and preliminary results of sensing and detection for an extravascular implantable cardioverter-defibrillator
CD Swerdlow, X Zhang, R Sawchuk, S Greenhut… - Clinical …, 2021 - jacc.org
Objectives This study reports the sensing and arrhythmia detection performance of a novel
extravascular (EV) implantable cardioverter-defibrillator (ICD) in a first-in-human pilot study …
extravascular (EV) implantable cardioverter-defibrillator (ICD) in a first-in-human pilot study …
[HTML][HTML] Emerging concepts on infection of novel cardiac implantable devices
MS Ramadan, R Gallo, F Patauner… - Reviews in …, 2022 - imrpress.com
Novel cardiac devices, including the MitraClip system, occluder devices, leadless
pacemakers, and subcutaneous implantable cardioverter defibrillators (S-ICD), are mostly …
pacemakers, and subcutaneous implantable cardioverter defibrillators (S-ICD), are mostly …